Symptoms of Hypogonadism Caused By 5α-Reductase Inhibitors
ثبت نشده
چکیده
Hypogonadism is a disease to cause decreased energy, libido loss, body hair loss, mood depression, muscle volume reduction, and hot flashes [1-3]. 5α-reductase inhibitors (5-ARIs) are administered orally for male pattern alopecia and benign prostatic hyperplasia due to decrease of dihydrotestosterone, a potent male hormone [4]. 5-ARIs are generally known not to cause hypogonadism because 5-ARIs do not decrease total testosterone (TT) [4-8]; decreased testosterone causes hypogonadism. In recent years, 2 reports suggested that 5-ARIs may decrease TT to cause symptoms of hypogonadism [9,10], but there is no report that 5-ARIs caused cold sensation and paresthesia of lower extremities. We here report a patient with strong cold sensation and paresthesia of lower extremities and symptoms of hypogonadism due to 2 types of oral 5-ARIs. The one was finasteride, an imported medicine for personal use, and the other was saw palmetto, an over-the-counter drug in Japan.
منابع مشابه
Synthesis of Novel 17-Oxo-17a-Aza-D-Homo-3, 5-Seco-Steroids as Potential 5α-Reductase Inhibitors
Benign prostatic hyperplasia (BPH) is a non-malignant enlargement of the prostate gland. Itis a leading disorder of the elderly male population. Excessive production of dihydrotestosteronehas been implicated in this pathological condition. Steroidal 5α-reductase is a membrane boundNADPH dependent enzyme which is responsible for the conversion of testosterone (T) todihydrotestosterone (DHT). The...
متن کاملImprovement of Tissue Survival of Skin Flaps by 5α-Reductase Inhibitors: Possible Involvement of Nitric Oxide and Inducible Nitric Oxide Synthase
Background: Skin flap grafting is a popular approach for reconstruction of critical skin and underlying soft tissue injuries. In a previous study, we demonstrated the beneficial effects of two 5α-reductase inhibitors, azelaic acid and finasteride, on tissue survival in a rat model of skin flap grafting. In the current study, we investigated the involvement of nitric oxide and inducible nitric o...
متن کاملThe Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
With aging, abnormal benign growth of the prostate results in benign prostate hyperplasia (BPH) with concomitant lower urinary tract symptoms (LUTS). Because the prostate is an androgen target tissue, and transforms testosterone into 5α-dihydrotestosterone (5α-DHT), a potent androgen, via 5α-reductase (5α-R) activity, inhibiting this key metabolic reaction was identified as a target for drug de...
متن کاملQsar Studies on Human 5α-reductase Inhibitors: Unsaturated 3-carboxysteroids
Benign prostatic hyperplasia (BPH), a leading disorder of the elderly male population, is the nonmalignant enlargement of the prostate gland. It involves an increase in cell numbers in both the epithelial and stromal elements within the periurethal transition zone of the prostate (1). BPH prevalence increases with age affecting around 80% by the age of 80 years causing considerable voiding dysf...
متن کاملMorphine and kisspeptin influences on 5-α reductase and aromatase gene expression in adult male rats
Objective(s): Kisspeptin and opioids are important factors for controlling GnRH/LH secretion. In present study, influences of kisspeptin or morphine were investigated on 5α- reductase or aromatase (CYP19) genes expression in the hypothalamus, testis and liver. It aimed to investigate whether kisspeptin pathway may control morphine effects on plasma concentration of tes...
متن کامل